ArticleIntensive care medicine2018
Position paper for the organization of ECMO programs for cardiac failure in adults.
Article in Intensive care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05090930 (Development of Innovative Technologies for the Treatment of Pulmonary and Heart Failure to Prolong Human's Life), which is not on this map. Cited by 112 papers, 11 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development of Innovative Technologies for the Treatment of Pulmonary and Heart Failure to Prolong Human's Life
Who cites it
112 citing papers in PubMed, 11 syntheses or guidelines pooled it, 304 citations in OpenAlex.
- Pooled it
- Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review.Critical care (London, England) · 2022Pooled it
- Human factors in ECLS - A keystone for safety and quality - A narrative review for ECLS providers.Artificial organs · 2022Pooled it
- [Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure : Short version of the S3 guideline].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2021Guideline
- [Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure : Short version of the S3 guideline].Der Anaesthesist · 2021Guideline
- Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience.Interactive cardiovascular and thoracic surgery · 2020Pooled it
- EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.European heart journal · 2020Guideline
- Extracorporeal Life Support: The Next Step in Moderate to Severe ARDS-A Review and Meta-Analysis of the Literature.BioMed research international · 2019Pooled it
- Clinical Efficacy of Extracorporeal Cardiopulmonary Resuscitation for Adults with Cardiac Arrest: Meta-Analysis with Trial Sequential Analysis.BioMed research international · 2019Pooled it
- Extracorporeal cardiopulmonary resuscitation for cardiac arrest: A systematic review.Resuscitation · 2018Pooled it
- Multiparameters associated to successful weaning from VA ECMO in adult patients with cardiogenic shock or cardiac arrest: Systematic review and meta-analysis.Annals of cardiac anaesthesiaPooled it
- Effects of early continuous renal replacement therapy in critically ill patients requiring ECMO treatment: results of a randomised controlled trial.Open heart · 2026Trial
- Extracorporeal membrane oxygenation, acute kidney injury, fluid balance, and continuous renal replacement therapy: Acute Disease Quality Initiative (ADQI) and Extracorporeal Life Support Organization (ELSO) joint consensus conference.Intensive care medicine · 2026Article
- Extracorporeal Life Support in Severe Accidental Hypothermia: Mechanisms, Challenges and Clinical Horizons.Journal of clinical medicine · 2026Review
- Percutaneous Versus Surgical Cannulation for Femoro-Femoral Venoarterial Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study on Cannulation-Related Complications.Artificial organs · 2026Article
- Global research trends and hotspots in extracorporeal membrane oxygenation for cardiogenic shock: a bibliometric review and knowledge mapping approach (1990-2024).Journal of thoracic disease · 2026Article
- Cardiogenic Shock Systems of Care Best Practices. Part 2: The Shock Team and Inpatient Management.US cardiology · 2026Review
- ECMO in hinterland-feasibility and challenges (case-based narrative review).Frontiers in medicine · 2026Review
- Decisional conflict among Chinese family caregivers prior to ECMO initiation: a cross-sectional study.Scientific reports · 2025Article
- Radiomics-enhanced modelling approach for predicting the need for ECMO in ARDS patients: a retrospective cohort study.Scientific reports · 2025Article
52 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
39 authors at 20 institutions in 16 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.